Cleared Traditional

K163418 - Diazyme DZ-Lite Total beta-hCG Test System

K163418 is an FDA 510(k) clearance for Diazyme DZ-Lite Total beta-hCG Test System, manufactured by Diazyme Laboratories. The device is a Class 2 Chemistry device with product code DHA cleared through the Traditional 510(k) pathway after a 255-day FDA review.

K163418 · Diazyme Laboratories · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2017
Decision
255d
Days
Class 2
Risk

K163418 is an FDA 510(k) clearance for the Diazyme DZ-Lite Total beta-hCG Test System. Classified as System, Test, Human Chorionic Gonadotropin (product code DHA), Class II - Special Controls.

Submitted by Diazyme Laboratories (Poway, US). The FDA issued a Cleared decision on August 18, 2017 after a review of 255 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1155 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Diazyme Laboratories devices

FDA 510(k) Submission Details - K163418

510(k) Number K163418 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 06, 2016
Decision Date August 18, 2017
Days to Decision 255 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
167d slower than avg
Panel avg: 88d · This submission: 255d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DHA Device Classification - Class 2, Special Controls

Product Code DHA System, Test, Human Chorionic Gonadotropin
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1155
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - DHA System, Test, Human Chorionic Gonadotropin

All 46
Devices cleared under the same product code (DHA) and FDA review panel - the closest regulatory comparables to K163418.
MAGLUMI 2000 HCG/ß-HCG
K192547 · Shenzhen New Industries Biomedical Engineering Co., Ltd. · Jan 2020
Atellica IM Total hCG (ThCG)
K192790 · Siemens Healthcare Diagnostics, Inc. · Oct 2019
Alinity i Total ß-hCG Reagent Kit, Alinity i System
K170317 · Abbott Laboratories · Oct 2017
i-STAT Total beta-hCG Test, i-STAT Total beta-hCG Controls, i-STAT Total beta-hCG Calibration Verification Materials
K133002 · Abbott Point of Care, Inc. · Apr 2015
ACCESS TOTAL BHCG (5TH IS)
K130020 · Beckman Coulter, Inc. · Oct 2013
LIAISON XL HCG
K131037 · DiaSorin, Inc. · Sep 2013